Santen Pharmaceutical Investor

Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.

Total Funding: 59000000 EUR
Headquarters: United States
Funding Status: M&A
Employee Number: 1001-5000
Last Funding Type: Series D
Number Of Exists: 3
Last Funding Date: 2009-09-26
Investors Number: 8
Founded Date: 1890-01-01
Industry: Biotechnology, Health Care, Manufacturing, Science and Engineering